Andrew Kidd

Andrew Kidd

Chief Executive Officer at Tentarix Biotherapeutics LP

Net worth: 9 700 $ as of 2023-12-30

48 year
Health Technology
Consumer Services

Profile

Andrew Kidd is currently the Chief Executive Officer at Tentarix Biotherapeutics LP and Tentarix Biotherapeutics, Inc. He previously worked as the CEO, Chief Financial & Accounting Officer at Aptinyx, Inc. and held positions at Baxter International, Inc. and Baxter Corp.
Dr. Kidd completed his undergraduate education at the University of Oxford and the University of Cambridge.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-04-23 101,043 ( 0.15% ) 9 700 $ 2023-12-30

Andrew Kidd active positions

CompaniesPositionStart
Chief Executive Officer 2024-04-22
Tentarix Biotherapeutics, Inc. Chief Executive Officer 2024-03-31
All active positions of Andrew Kidd

Former positions of Andrew Kidd

CompaniesPositionEnd
APTINYX Chief Executive Officer 2023-06-29
Corporate Officer/Principal -
BAXTER INTERNATIONAL INC. Corporate Officer/Principal -
See the detail of Andrew Kidd's experience

Training of Andrew Kidd

University of Oxford Undergraduate Degree
University of Cambridge Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Kidd's experience

Connections

30

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
APTINYX

Health Technology

BAXTER INTERNATIONAL INC.

Health Technology

Private companies3

Health Technology

Health Technology

Tentarix Biotherapeutics, Inc.

See company connections